Wei Jia

ORCID: 0000-0001-6004-7634 · 4 papers in corpus
observational 2025
Triptorelin associated adverse events evaluated using FAERS pharmacovigilance data
Scientific reports ·doi:10.1038/s41598-025-16734-7

Triptorelin, a gonadotropin-releasing hormone(GnRH) agonist, is approved by the US Food and Drug Administration(FDA) for treating advanced prostate cancer, endometriosis, and central precocious puberty(CPP) in children aged ≥ 2 years. This …

other 2013
Translational research in complementary and alternative medicine
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2013/296817
rct 2011
Application of protective device in cesarean section

Objectives: To investigate on the effect of the use of protective device in the cesarean section.Methods: Eight hundred cases of pregnant women,who received cesarean section delivery in our hospital from January,2007 to January,2008,were ra…

lab-animal 2010
Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid
Molecular cancer ·doi:10.1186/1476-4598-9-140

BACKGROUND: Although the incidence of melanoma in the U.S. is rising faster than any other cancer, the FDA-approved chemotherapies lack efficacy for advanced disease, which results in poor overall survival. Lysophosphatidic acid (LPA), auto…